Virtual Medicinal Product (VMP)
-
Pentazocine 50mg suppositories
Name Details
Current Name
Pentazocine 50mg suppositories
|
Start Date
17-03-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- suppository
- Unit Dose UOM
- suppository
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 3 (CD No Register Exempt Safe Custody)
- Route
- Rectal
- Form
- Suppository
- Ontology Form/Route
- suppository.rectal
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N02AD01
BNF |
Current BNF
04070200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04070200
|
Start Date
21-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42016411000001107 |
03-07-2023 |
|
322604007 |
17-03-2003 |
02-07-2023 |
VMP Ingredients
Name
Pentazocine lactate
Basis of strength description
Based on Base Substance
BOSS
Pentazocine
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Pentazocine
-
VMP
(Current) Pentazocine 50mg suppositories
Virtual Medicinal Product Pack (VMPP) Information